ALLR
Allarity Therapeutics Inc
NASDAQ: ALLR · HEALTHCARE · BIOTECHNOLOGY
$1.35
-2.17% today
Updated 2026-04-30
Market cap
$21.83M
P/E ratio
—
P/S ratio
68.22x
EPS (TTM)
$-0.78
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
Allarity Therapeutics Inc (ALLR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-912.00%
ROE
-103.80%
ROA
-38.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | — | $-81185.00 | — | — | — |
| 2014 | $9974.00 | $-68661.00 | -459.71% | -688.40% | -688.40% |
| 2015 | $362287.00 | $-1.15M | 100.00% | -385.48% | -316.59% |
| 2016 | $143277.00 | $-3.68M | 100.00% | -3,132.12% | -2,570.36% |
| 2017 | $1.46M | $-4.90M | -52.19% | -263.43% | -335.69% |
| 2018 | $1.46M | $-2.29M | -247.87% | -341.19% | -156.97% |
| 2019 | $120000.00 | $-14.31M | 100.00% | -14,675.83% | -11,927.50% |
| 2020 | $0.00 | $-6.60M | — | — | — |
| 2021 | $0.00 | $-26.65M | — | — | — |
| 2022 | $0.00 | $-16.06M | — | — | — |
| 2023 | $0.00 | $-11.90M | — | — | — |
| 2024 | $0.00 | $-24.52M | — | — | — |
| 2025 | $320000.00 | $-11.23M | 100.00% | -3,939.06% | -3,509.69% |